Urgent.News

What's breaking now, across thousands of outlets.

Culture

Lita Ford Inks Record Deal for New Album, Teases New Single “Dracula”

Lita Ford has signed a new record deal with Frontiers Music Srl and shared a snippet of her new single "Dracula." Lita Ford Inks Record Deal for New Album, Teases New Single “Dracula” Langdon Hickman

Lita Ford Inks Record Deal for New Album, Teases New Single “Dracula”

Lita Ford has inked a new record deal with Frontiers Music Srl and is set to release a forthcoming album. The iconic singer and guitarist revealed that she has found the ideal team to bring her dark fairytale album to life. She expressed her excitement about the collaboration with Frontiers Music Srl, stating, "I am so happy to say I have officially sealed the deal with Frontiers Music Srl, as we are thrilled, excited and ready to rise with the 1st new single on October 27th, 2026."

Jeff Stevenson, General Manager of Frontiers Label Group, praised Lita Ford, calling her a true rock icon whose influence and musicianship inspire generations of fans and musicians globally. Stevenson emphasized the label's excitement about Lita's forward-thinking approach and her choice to join the Frontiers family. Ford is currently preparing for a show in Las Vegas on October 30th, with tickets available for purchase. In the meantime, fans can hear a sample of her new single, "Dracula," and view its cover artwork.

Written by urgent.news from Consequence's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at consequence.net →

More in Culture

Meta Hit With $25 Billion Fine in Cambridge Analytica Privacy Case

New Mexico Judge Francis J. Mathew's ruling comes after a jury found more than 43 million violations of state consumer protection laws The post Meta Hit With $25 Billion Fine in Cambridge Analytica…

  • Meta fined $25 billion for privacy violations in New Mexico case.
  • Judge Mathew ruled 44 million consumer protection law violations.
  • Company plans to appeal decision, citing lack of consumer harm proof.

More from Wednesday 21 October →